1.	Cell Therapy for Metastatic Melanoma Using CD8 Enriched Tumor Infiltrating Lymphocytes Phase: Phase II, Phase I Type: Treatment Status: Active Age: 18 and over Sponsor: NCI Protocol IDs: 110011, 11-C-0011, NCT01236573
2.	Interleukin-12 Gene and in Vivo Electroporation-Mediated Plasmid DNA Vaccine Therapy in Treating Patients With Merkel Cell Cancer Phase: Phase II Type: Biomarker/Laboratory analysis, Treatment Status: Active Age: 18 and over Sponsor: NCI, Other Protocol IDs: 7248, NCI-2011-01221, P30CA015704, NCT01440816
3.	Trial of pIL-12 Electroporation Malignant Melanoma Phase: Phase II Type: Treatment Status: Active Age: 18 and over Sponsor: Other Protocol IDs: 11854, NCT01502293
4.	Phase II Intratumoral pIL-12 Electroporation in Cutaneous Lymphoma Phase: Phase II Type: Treatment Status: Approved-not yet active Age: 18 and over Sponsor: Other, Pharmaceutical / Industry Protocol IDs: CC# 10861, NCT01579318
5.	Phase I Study of Adenoviral Vector Delivery of the Interleukin-12 Gene in Patients With Liver Metastases Secondary to Colorectal Cancer Phase: Phase I Type: Treatment Status: Active Age: Adult Sponsor: NCI Protocol IDs: MTS-GCO-975642, MTS-GCO-971592, NCT00072098